New incentives needed to develop antibiotics to fight superbugs

NEW YORK, May 27 (Reuters) - Drugmakers are renewing efforts

to develop medicines to fight emerging antibiotic-resistant

bacteria, but creating new classes of drugs on the scale needed

is unlikely...

Read more